Skip to main content
Clinical Trials/CTRI/2016/08/007180
CTRI/2016/08/007180
Completed
未知

An observational study to evaluate early treatment response in peripheral blood on Day 15 by flow cytometry in B cell Acute Lymphoblastic Leukemia patients treated with ICiCLe protocol

Tata Memorial Hospital0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- B cell Acute Lymphoblastic Leukemia
Sponsor
Tata Memorial Hospital
Enrollment
100
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • B acute lymphoblastic leukemia patients treated on Indian Childhood Collaborative Leukemia group(ICiCLe)protocol

Exclusion Criteria

  • Patients with following high risk cytogenetics\-
  • (i) MLL rearranged leukaemias, e.g. t(4;11\) (q21;q23\)
  • (ii) Low hypodiploidy ( \<45 chromosomes)
  • (iii) t(17;19\) (q22;p13\) (TCF3\-HLF)
  • (iv) Intrachromosomal amplification of chromosome 21 (iAMP21\)
  • (v) t(9;22\) (q34;q11\) (BCR\-ABL)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The clinical study for evaluating the early efficacy and safty of alpha-1-adrenoreceptor antagonists in patient with benign prostatic hyperplasia.Benign prostatic hyperplasia (BPH)
JPRN-UMIN000005151Department of Renal and Urologic Surgery, Asahikawa Medical University100
Active, not recruiting
Phase 1
A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaReCOVID-19 InfectionMedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-001449-38-GBChelsea and Westminster Hospital NHS Foundation Trust450
Completed
Not Applicable
Exploratory clinical study of first-line treatment for patients with advanced EGFR mutation-positive non-squamous non-small-cell lung canceradvanced EGFR mutation-positive non-squamous non-small cell lung cancer
JPRN-UMIN000015414Department of Thoracic Oncology Osaka Medical Center for Cardiovascular diseases40
Not yet recruiting
Phase 3
Investigating the effect of early medical treatment with enoxaparin on the rate of successful fertility following assisted reproductive methodsInfertility.Female infertility
IRCT20220530055028N1Karaj University of Medical Sciences80
Not yet recruiting
Not Applicable
Early detection of the effectiveness of treatment with biologicals in patients with severe asthma using fluctuation analysis of biomarkers
NL-OMON56494Academisch Medisch Centrum48